Mortality from Multiple Myeloma Within One Year Following Autologous Stem Cell Transplantation: Defining an Ultra-high Risk Population-Reference-Cited by-同舟云学术

Mortality from Multiple Myeloma Within One Year Following Autologous Stem Cell Transplantation: Defining an Ultra-high Risk Population

Published:2021-07 Issue:7 Volume:21 Page:476-482
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Cherniawsky Hannah M.,AlAhwal Hatem,Mourad Yasser Abou,Forrest Donna,Gerrie Alina,Kuchenbauer Florian,Nantel Stephen H.,Narayanan Sujaatha,Nevill Thomas,Power Maryse,Sanford David,Toze Cynthia,White Jennifer,Escano Leo,Sutherland Heather,Song Kevin

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference37 articles.

1. International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma;Kumar;Lancet Oncol,2016

2. Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients;Kumar;Leukemia,2014

3. Early mortality in the patients with multiple myeloma who were treated upfront with a novel agent-containing regimen;Lee;Clin Lymphoma Myeloma Leuk,2015

4. Risk of early mortality in patients with newly diagnosed multiple myeloma;Hsu;Medicine (Baltimore),2015

5. Trends in early mortality from multiple myeloma (MM): a population-based analysis;Kumar;Blood,2019

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of Autologous Stem Cell Transplantation in Patients with Ultra-High-Risk Multiple Myeloma;Transplantation and Cellular Therapy;2023-12

2. Cellular Immunotherapies for Multiple Myeloma: Current Status, Challenges, and Future Directions;Oncology and Therapy;2022-02-01